BCMAS TERMS

Anatomy and Physiology Lab Exa
vg vg vg vg


m 1vg

Studyvgonlinevgatvghttps://quizlet.com/_ua65q
BCMAS TERMS

AbbreviatedvgNewvgDrugvgApplicationvg-vganswer--
ApplicationvgtovgbevgsubmittedvgforvgFDAvgapprovalvgofvggenericvgdrugs,vgwherevgdatavgaboutvgbioequivalencevgorvgthera
euticvgequivalencevgmustvgbevgclearlyvgdemonstrated.vgCompaniesvgarevgallowedvgtovgsubmitvgANDAvgoncevgthevgpaten
gofvgbioequivalent vgbrand-namevgdrugsvghavevgexpired.



ActivevgPharmaceuticalvgIngredientsvg(API's)vg-vganswer--
Rawvgchemicalvgmaterialsvgthatvgarevgusedvgtovgmanufacturevgdrugs

AdjuvantvgTherapyvg-vganswer--
Additionalvgtreatmentvgtovgthevgmainvgorvginitialvgtreatmentvgthatvgisvgdesignedvgtovgmaximizevgitsvgeffectiveness

Adulterationvg-vganswer--
RefersvgtovgpharmaceuticalvgproductsvgthatvgfailvgtovgmeetvghealthvgorvgsafetyvgstandardsvgasvgdeterminedvgbyvgFDA.

alternativevghypothesisvg-vganswer--Alsovgknownvgasvgresearchvghypothesisvg-
vghypotheticalvgtestingvgassumingvgthatvgtherevgisvgdifferencevgbetweenvgthevggroups/outcomesvgofvginterest.



Biasvg-vganswer--
Systematicvgerrorvginvgsamplingvgandvgmeasurementvgthatvgleadsvgtovganvgincorrectvgconclusion.vgBiasvgcommonlyvgocc
svgwhilevgconductingvgavgclinicalvgtrialvgandvgisvgusuallyvgduringvgselection/
enrollmentvgofvgavgstudyvgparticipantsvgandvgmeasurementvgofvgexposure/outcome.

Biocompatibilityvg-vganswer--
Thevgpropertiesvgofvgmaterialsvgbeingvgcompatiblevgwithvglivingvgtissuevgorvgavglivingvgsystem,vgbyvgnotvgbeingvgtoxic,vginju
ous,vgorvgnotvgelicitingvglocalvgorvgsystemicvgresponsesvgfromvgavglivingvgsystemvgorvgtissue.

Bioequivalencevg-vganswer--
Thevgpropertyvgwhereinvgtwovgdrugsvgwithvgidenticalvgactivevgingredientsvgorvgtwovgdifferentvgdosagevgformsvgofvgthevgsam
vgdrugvgpossessvgsimilarvgbioavailabilityvgandvgproducevgthevgsamevgeffectvgatvgthevgsitevgofvgphysiologicalvgactivity



BLAvg-vganswer--
Biologicvglicensevgapplication:vgApplicationvgtovgbevgsubmittedvgforvgFDAvgapprovalvgofvgbiosimilarvgproducts

Biologicsvg-vganswer--
Biologicalvgproductsvgsuchvgasvgvaccines,vgbloodvgandvgbloodvgcomponents,vgallergenics,vgsomaticvgcells,vggenevgthera
,vgtissuesvgandvgrecombinantvgtherapeuticvgproteins.vgTheyvgarevgisolatedvgfromvgnaturalvgsources.vgGene-
basedvgandvgcellularvgbiologicsvgoftenvgarevgatvgforefrontvgofvgbiomedicalvgresearch,vgandvgmayvgbevgusedvgtovgtreatvgavgv
etyvgofvgcomplicatedvgorvgrarevgdiseases.

Biomarkersvg-vganswer--
Characteristicsvgthatvgarevgobjectivelyvgmeasuredvgandvgevaluatedvgasvganvgindicatorvgofvgnormalvgbiologicalvgprocesse
gpathogenicvgprocesses,vgorvgpharmacologicvgresponsesvgtovgavgtherapeuticvgintervention.



Biosimilarsvg-vganswer--
BiologicalvgproductsvgthatvgarevgapprovedvgbasedvgonvgshowingvgthatvgtheyvgarevghighlyvgsimilarvgtovgalreadyvgFDA-
1vg/
vg13

, Anatomy and Physiology Lab Exa
vg vg vg vg


m 1
vg

Studyvgonline
approvedvgbiological vgatvghttps://quizlet.com/_ua65q
vgproducts vgandvghavevgbeenvgshownvgtovghavevgnovgclinicallyvgmeaningfulvgdifferencesvgfromvgthev

readyvgapprovedvgbiologicalvgproducts.

Casevgreportvg-vganswer--
Typevgofvgclinicalvgstudyvgthatvganalyzesvgavggroupvgofvgpeoplevgwithvgsinglevgexposurevgorvgoutcome.vgExposurevgcanvgb
gavgdisease,vgavgriskvgfactorvgorvganvgintervention.



Casevgseriesvg-vganswer--
Typevgofvgclinicalvgstudyvgthatvganalyzesvgavggroupvgofvgpeoplevgwithvgsinglevgexposurevgorvgoutcome.vgExposurevgcanvgb
gavgdisease,vgavgriskvgfactorvgorvganvgintervention.



Casevgcontrolvgstudyvg-vganswer--
Typevgofvgretrospectivevgstudyvgwherevgthevgselectionvgofvgparticipantsvgisvgbasedvgonvgthevgoutcomevgandvgthenvglooksv
ackwardsvgtovgdeterminevgpossiblevgexposures

CDERvg-vganswer--Centervgforvgdrugvgevaluationvgandvgresearchvg-
vgavgdepartmentvgwithinvgFDAvgthatvgperformsvganvgessentialvgpublicvghealthvgtaskvgbyvgmakingvgsurevgthatvgsafevgandvgef

ctivevgdrugsvgarevgavailablevgtovgimprovevgthevghealthvgofvgpeoplevginvgthevgUnitedvgStates.

chronicvgdiseasesvg-vganswer--Diseasesvgthatvglastvgthreevgmonthsvgorvgmore

CMSvg-vganswer--Centervgforvgmedicarevgandvgmedicaidvgservicesvg-
vgFederalvgagencyvgwithinvgthevgUSvgHHSvg(HumanvgandvgHealthvgservices)



Cohortvgstudyvg-vganswer--
Typevgofvgclinicalvgstudyvgthatvgisvgdesignedvgtovgfollowvgavggroupvgofvgpeoplevgandvgthenvglookvgatvghowvgeventsvgdiffervga
ongvgpeoplevgwithinvgthevggroup.vgProspectivevgandvgretrospective

Compositevgclinicalvgendpointvg-vganswer--
Avgsinglevgmeasurevgofvgeffect,vgbasedvgonvgavgcombinationvgofvgindividualvgendpoints.vgThisvgtypevgofvgendpointvgisvgpar
ularlyvgusefulvgforvgdrugsvgthatvgcanvgbenefitvgpatientsvginvgseveralvgwaysvgorvgifvgcomponentvgeventsvgarevginfrequent.

Contrivancevg-vganswer--Avgdevicevgthatvgcanvgbevgusedvgforvgsomevgparticularvgpurposes

Cost-benefitvganalysisvg-vganswer--Methodvgusedvgtovgmeasurevginputsvgandvgoutcomesvginvgmonetaryvgvalue.vgCost-
benefitvganalysisvgisvgoftenvgperformedvgtovgdeterminevghowvginstitutionsvgcanvgbestvgspendvgtheirvgresourcesvgtovgprodu
vgmonetaryvgbenefits.



Cost-effectivenessvganalysisvg-vganswer--
Methodvgusedvgtovgmeasurevgcostsvginvgmonetaryvgvaluevgandvgoutcomesvginvgnaturalvghealthvgunitsvg(suchvgasvgcholest
olvglevel,vgbloodvgpressure).

Cost-minimizationvganalysisvg-vganswer--
Methodvgusedvgtovgmeasurevgcostvginvgmonetaryvgvalue,vgassumingvgoutcomesvgtovgbevgequivalent

Cost-utilityvganalysisvg-vganswer--
Methodvgusedvgtovgmeasurevgthevghealthvgoutcomesvginvgtermsvgofvgthevgnumbervgofvgyearsvglivedvginvgfullvghealthvgbyvgth
beneficiaries.vgThevgunitvgofvgmeasurementvgisvgnotvgmonetaryvgtermsvgbutvgisvgexpressedvginvgquality-
adjustedvglifevgyears.

Cross-sectionalvgstudyvg-vganswer--Surveyvgorvgprevalencevgstudy
2vg/
vg13